Lumida
/UVV
⌘K
Universal Corp

Universal Corp

UVV
$45.18USD-0.33%-0.15 today

MARKET CAP

1.1B

P/E (TTM)

13.3x

FWD P/E

DAY RANGE

$45 – $46

52W RANGE

$43
$59

AI Summary

Stalk
StalkMedium

Despite a sustained long-term downtrend, the Post-Capitulation mean-reversion pattern indicates selling exhaustion and a potential bounce from oversold levels. However, price remains stuck below declining 9/20 EMAs without clear acceptance above the 20-day EMA resistance. Under the Stable strategy’s patient, structure-first approach, bullish execution is deferred until a definitive breakout above EMA resistance or a pullback into the established support zone offers a cleaner entry.

  • Q4 revenue +2% YoY at $715M, driven by flu-cured and burley tobacco
  • Ingredients revenue reached $265.2M, reflecting demand for health-oriented products
  • Q4 operating loss of $15M and $43M inventory write-downs signal margin pressure
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$2.0B$2.1B$2.6B$2.7B$2.9B
YoY %+3.8%+6.1%+22.2%+7.0%+7.2%
P / Sales0.7x0.7x0.5x0.5x0.5x
EV / Sales1.1x1.2x1.0x1.0x0.9x
Gross Profit, Adj.$386.0M$408.9M$458.3M$536.1M$548.7M
YoY %+8.2%+5.9%+12.1%+17.0%+2.3%
Margin %19.5%19.4%17.8%19.5%18.6%
EV / Gross Profit5.9x6.3x5.4x5.0x4.8x
EBITDA, Adj.$210.9M$223.3M$238.4M$283.9M$289.0M
YoY %+22.4%+5.9%+6.8%+19.1%+1.8%
Margin %10.6%10.6%9.3%10.3%9.8%
EV / EBITDA10.7x11.5x10.3x9.4x9.1x
EBIT$147.8M$160.3M$181.1M$222.0M$218.7M
YoY %+17.0%+8.5%+12.9%+22.6%-1.5%
Margin %7.5%7.6%7.0%8.1%7.4%
EV / EBIT15.3x16.0x13.6x12.1x12.1x
Net Income$87.4M$86.6M$124.1M$119.6M$95.0M
YoY %+21.9%-1.0%+43.3%-3.6%-20.5%
Net Margin4.4%4.1%4.8%4.4%3.2%
EPS (GAAP)$3.53$3.47$4.97$4.78$3.78
YoY %+23.4%-1.7%+43.2%-3.8%-20.9%